Drawing for CORDEN PHARMA

USPTO serial 79380274

CORDEN PHARMA

Reviewed by CopyMark Law Group

Reg. 7504818Status 700Registered
Filing date
Status date
Registration date
Sep 17, 2024
Examiner
RADEMACHER, APRIL LUEDERS
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CORDEN PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey H. Handelsman

Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.1950 Roland Clarke PlaceReston, VA 20191-1411United States

Goods and services

ClassDescriptionStatusFirst use
040Custom manufacture of pharmaceutical products; treatment of chemical products; recycling of chemical productsACTIVE—
042Pharmaceutical research services; qualitative evaluation of pharmaceutical products; development of pharmaceutical products; inspection of pharmaceutical products; research in the field of pharmaceutical products; testing on pharmaceutical products; pharmaceutical product development services; development of pharmaceutical preparations and medicines; laboratory research services concerning pharmaceutical products; research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; provision of information concerning the results of clinical trials for pharmaceutical products; industrial packaging design services; chemical laboratory services; chemical engineering services; chemical analysis; chemical research; testing of chemical products; chemical technology research; analysis of the chemical composition of liquids; evaluation of chemical information to estimate risk levelsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 22, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 15, 2025FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 4, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 4, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 26, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 25, 2025FIMPFINAL DISPOSITION PROCESSED—
Dec 18, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 17, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 17, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 2024GPNXNOTIFICATION PROCESSED BY IB—
Jul 2, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 2, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 1, 2024GPNXNOTIFICATION PROCESSED BY IB—
Jun 14, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 13, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 12, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 12, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 24, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 23, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 23, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 23, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 23, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 23, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 23, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 23, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 23, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 23, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 22, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 26, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 26, 2024RFRRREFUSAL PROCESSED BY MPU—
Apr 13, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 12, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2024DOCKASSIGNED TO EXAMINER—
Oct 17, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 12, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 5, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance